Transglutaminase 2 - A novel inhibitor of adipogenesis

Cell Death and Disease

Volumn 6, Issue 8, 2015, Pages

  Myneni, V D ^a   Melino, G ^b   Kaartinen, M T ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; FIBRONECTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEIN KINASE B; WNT PROTEIN; ACTIN; CCAAT ENHANCER BINDING PROTEIN; CEBPA PROTEIN, MOUSE; CTNNB1 PROTEIN, MOUSE; DLK1 PROTEIN, MOUSE; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RHO KINASE; SIGNAL PEPTIDE;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ADIPOCYTE; ANIMAL; CYTOLOGY; DEFICIENCY; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; MAMMALIAN EMBRYO; METABOLISM; PHOSPHORYLATION; PROTEIN TRANSPORT; WHITE ADIPOSE TISSUE;

ACTINS; ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE, WHITE; ANIMALS; BETA CATENIN; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; EMBRYO, MAMMALIAN; FIBROBLASTS; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; PPAR GAMMA; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; TRANSGLUTAMINASES;

EID: 84989859618     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.238     Document Type: Article

References (67)

1. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444: 875-880.
2. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840-846.
3. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O et al. Dynamics of fat cell turnover in humans. Nature 2008; 453: 783-787.
4. Virtue S, Vidal-Puig A. It's not how fat you are, it's what you do with it that counts. PLoS Biol 2008; 6: e237.
5. Tchoukalova Y, Koutsari C, Jensen M. Committed subcutaneous preadipocytes are reduced in human obesity. Diabetologia 2007; 50: 151-157.
6. Spiegelman BM, Ginty CA. Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes. Cell 1983; 35: 657-666.
7. Kanzaki M, Pessin JE. Insulin-stimulated GLUT4 translocation in adipocytes is dependent upon cortical actin remodeling. J Biol Chem 2001; 276: 42436-42444.
8. Feve B. Adipogenesis: cellular and molecular aspects. Best Pract Res Clin Endocrinol Metab 2005; 19: 483-499.
9. Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 2011; 12: 722-734.
10. Myneni VD, Hitomi K, Kaartinen MT. Factor XIII-A transglutaminase acts as a switch between preadipocyte proliferation and differentiation. Blood 2014; 124: 1344-1353.
11. Eckert RL, Kaartinen MT, Nurminskaya M, Belkin AM, Colak G, Johnson GV et al. Transglutaminase regulation of cell function. Physiol Rev 2014; 94: 383-417.
12. Gundemir S, Colak G, Tucholski J, Johnson GV. Transglutaminase 2: a molecular Swiss army knife. Biochim Biophys Acta 2012; 1823: 406-419.
13. Iismaa SE, Mearns BM, Lorand L, Graham RM. Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev 2009; 89: 991-1023.
14. Thomazy V, Fesus L. Differential expression of tissue transglutaminase in human cells. An immunohistochemical study. Cell Tissue Res 1989; 255: 215-224.
15. Fesus L, Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 2002; 27: 534-539.
16. Siegel M, Khosla C. Transglutaminase 2 inhibitors and their therapeutic role in disease states. Pharmacol Ther 2007; 115: 232-245.
17. Al-Jallad HF, Nakano Y, Chen JL, McMillan E, Lefebvre C, Kaartinen MT. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures. Matrix Biology 2006; 25: 135-148.
18. Long F, Ornitz DM. Development of the endochondral skeleton. Cold Spring Harb Perspect Biol 2013; 5: a008334.
19. Nurminsky D, Shanmugasundaram S, Deasey S, Michaud C, Allen S, Hendig D et al. Transglutaminase 2 regulates early chondrogenesis and glycosaminoglycan synthesis. Mech Dev 2011; 128: 234-245.
20. Song H, Chang W, Lim S, Seo HS, Shim CY, Park S et al. Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells. Stem Cells 2007; 25: 1431-1438.
21. Grosso H, Mouradian MM. Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications. Pharmacol Ther 2012; 133: 392-410.
22. Akimov SS, Belkin AM. Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 2001; 98: 1567-1576.
23. Murtaugh MP, Mehta K, Johnson J, Myers M, Juliano RL, Davies PJ. Induction of tissue transglutaminase in mouse peritoneal macrophages. J Biol Chem 1983; 258: 11074-11081.
24. Bernassola F, Federici M, Corazzari M, Terrinoni A, Hribal ML, De Laurenzi V et al. Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient. FASEB J 2002; 16: 1371-1378.
25. Belkin AM. Extracellular TG2: emerging functions and regulation. FEBS J 2011; 278: 4704-4716.
26. Klock C, Diraimondo TR, Khosla C. Role of transglutaminase 2 in celiac disease pathogenesis. Semin Immunopathol 2012; 34: 513-522.
27. Hudak CS, Sul HS. Pref-1 a gatekeeper of adipogenesis. Front Endocrinol (Lausanne) 2013; 4: 79.
28. Kim KA, Kim JH, Wang Y, Sul HS. Pref-1 (preadipocyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation. Mol Cell Biol 2007; 27: 2294-2308.
29. Wang Y, Kim KA, Kim JH, Sul HS. Pref-1, a preadipocyte secreted factor that inhibits adipogenesis. J Nutr 2006; 136: 2953-2956.
30. Faverman L, Mikhaylova L, Malmquist J, Nurminskaya M. Extracellular transglutaminase 2 activates beta-catenin signaling in calcifying vascular smooth muscle cells. FEBS Lett 2008; 582: 1552-1557.
31. Christodoulides C, Lagathu C, Sethi JK, Vidal-Puig A. Adipogenesis and WNT signalling. Trends Endocrinol Metab 2009; 20: 16-24.
32. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL et al. Inhibition of adipogenesis by Wnt signaling. Science 2000; 289: 950-953.
33. Maiuri L, Luciani A, Giardino I, Raia V, Villella VR, D'Apolito M et al. Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation. J Immunol 2008; 180: 7697-7705.
34. Janiak A, Zemskov EA, Belkin AM. Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. Mol Biol Cell 2006; 17: 1606-1619.
35. Noguchi M, Hosoda K, Fujikura J, Fujimoto M, Iwakura H, Tomita T et al. Genetic and pharmacological inhibition of Rho-associated kinase II enhances adipogenesis. J Biol Chem 2007; 282: 29574-29583.
36. Amano M, Nakayama M, Kaibuchi KRho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarityCytoskeleton (Hoboken) 2010; 67: 545-554.
37. Aubin D, Gagnon A, Sorisky A. Phosphoinositide 3-kinase is required for human adipocyte differentiation in culture. Int J Obes (Lond) 2005; 29: 1006-1009.
38. Kim JE, Chen J. regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 2004; 53: 2748-2756.
39. Smas CM, Sul HS. Pref-1 a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 1993; 73: 725-734.
40. Wang Y, Zhao L, Smas C, Sul HS. Pref-1 interacts with fibronectin to inhibit adipocyte differentiation. Mol Cell Biol 2010; 30: 3480-3492.
41. Moon YS, Smas CM, Lee K, Villena JA, Kim KH, Yun EJ et al. Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol Cell Biol 2002; 22: 5585-5592.
42. Lee K, Villena JA, Moon YS, Kim KH, Lee S, Kang C et al. Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). J Clin Invest 2003; 111: 453-461.
43. Villena JA, Choi CS, Wang Y, Kim S, Hwang YJ, Kim YB et al. Resistance to high-fat dietinduced obesity but exacerbated insulin resistance in mice overexpressing preadipocyte factor-1 (Pref-1): a new model of partial lipodystrophy. Diabetes 2008; 57: 3258-3266.
44. Wang Y, Sul HS. Pref-1 regulates mesenchymal cell commitment and differentiation through Sox9. Cell Metab 2009; 9: 287-302.
45. De Laurenzi V, Melino G. Gene disruption of tissue transglutaminase. Mol Cell Biol 2001; 21: 148-155.
46. Tarantino U, Oliva F, Taurisano G, Orlandi A, Pietroni V, Candi E et al. FXIIIA and TGF-beta over-expression produces normal musculo-skeletal phenotype in TG2-/- mice. Amino Acids 2009; 36: 679-684.
47. Moldes M, Zuo Y, Morrison RF, Silva D, Park BH, Liu J et al. Peroxisome-proliferatoractivated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. Biochem J 2003; 376: 607-613.
48. Girnun GD, Smith WM, Drori S, Sarraf P, Mueller E, Eng C et al. APC-dependent suppression of colon carcinogenesis by PPARgamma. Proc Natl Acad Sci USA 2002; 99: 13771-13776.
49. Liu J, Wang H, Zuo Y, Farmer SR. Functional interaction between peroxisome proliferatoractivated receptor gamma and beta-catenin. Mol Cell Biol 2006; 26: 5827-5837.
50. Weng T, Gao L, Bhaskaran M, Guo Y, Gou D, Narayanaperumal J et al. Pleiotrophin regulates lung epithelial cell proliferation and differentiation during fetal lung development via beta-catenin and Dlk1. J Biol Chem 2009; 284: 28021-28032.
51. Paul C, Sardet C, Fabbrizio E. The Wnt-target gene Dlk-1 is regulated by the Prmt5- associated factor Copr5 during adipogenic conversion. Biol Open 2015; 4: 312-316.
52. Galceran J, Sustmann C, Hsu SC, Folberth S, Grosschedl R. LEF1-mediated regulation of Delta-like1 links Wnt and Notch signaling in somitogenesis. Genes Dev 2004; 18: 2718-2723.
53. Andersen P, Uosaki H, Shenje LT, Kwon C. Non-canonical Notch signaling: emerging role and mechanism. Trends Cell Biol 2012; 22: 257-265.
54. Takada I, Kouzmenko AP, Wnt Kato S. and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol 2009; 5: 442-447.
55. Kawai M, Mushiake S, Bessho K, Murakami M, Namba N, Kokubu C et al. Wnt/Lrp/betacatenin signaling suppresses adipogenesis by inhibiting mutual activation of PPARgamma and C/EBPalpha. Biochem Biophys Res Commun 2007; 363: 276-282.
56. McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 2004; 6: 483-495.
57. Lee DH, Shi J, Jeoung NH, Kim MS, Zabolotny JM, Lee SW et al. Targeted disruption of ROCK1 causes insulin resistance in vivo. J Biol Chem 2009; 284: 11776-11780.
58. Singh US, Kunar MT, Kao YL, Baker KM. Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2. EMBO J 2001; 20: 2413-2423.
59. Chiquet M, Gelman L, Lutz R, Maier S. From mechanotransduction to extracellular matrix gene expression in fibroblasts. Biochim Biophys Acta 2009; 1793: 911-920.
60. Akimov SS, Belkin AM. Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFbeta-dependent matrix deposition. J Cell Sci 2001; 114: 2989-3000.
61. Telci D, Wang Z, Li X, Verderio EA, Humphries MJ, Baccarini M et al. Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling. J Biol Chem 2008; 283: 20937-20947.
62. Wang Z, Collighan RJ, Gross SR, Danen EH, Orend G, Telci D et al. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 alpha5beta1 integrin co-signaling. J Biol Chem 2010; 285: 40212-40229.
63. Rosner M, Hengstschlager M. Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. Hum Mol Genet 2008; 17: 2934-2948.
64. Pankov R, Yamada KM. Non-radioactive quantification of fibronectin matrix assembly. In: Bonifacino JS et al. (ed). Current Protocols in Cell Biology, Chapter 10, Unit 10. John Wiley & Sons: Hoboken, NJ, USA, 2004, p3.
65. Han J, Farmer SR, Kirkland JL, Corkey BE, Yoon R, Pirtskhalava T et al. Octanoate attenuates adipogenesis in 3T3-L1 preadipocytes. J Nutr 2002; 132: 904-910.
66. Han F, Adams CS, Tao Z, Williams CJ, Zaka R, Tuan RS et al. Transforming growth factorbeta1 (TGF-beta1) regulates ATDC5 chondrogenic differentiation and fibronectin isoform expression. J Cell Biochem 2005; 95: 750-762.
67. Tanabe Y, Koga M, Saito M, Matsunaga Y, Nakayama K. Inhibition of adipocyte differentiation by mechanical stretching through ERK-mediated downregulation of PPARgamma2. J Cell Sci 2004; 117: 3605-3614.